FDA Grants Fast-Track Designation To Cannabis Withdrawal Syndrome Drug
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
Medical News Today6y
What to know about weed withdrawal
Whether they use weed for recreational or medicinal purposes, people can develop withdrawal symptoms when they stop. These withdrawal symptoms may include cravings, restlessness, irritability ...
Monthly Prescribing Reference5d
FDA Grants Fast Track Status to PP-01 for Cannabis Withdrawal Syndrome
The Food and Drug Administration (FDA) has granted Fast Track designation to PP-01 (nabilone/gabapentin) for the mitigation of cannabis withdrawal ...